ResearcherCentre Hospitalier Universitaire Mohammed VIActive in the last 2 years
Rhizlane Belbaraka
Matched on ORCID iD 0000-0002-3947-775X; OpenAlex author ID A5003108792.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 4
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 3
- Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients. Last author DOI 10.1016/j.ctarc.2025.101036↗
- Severe and fatal interstitial lung disease induced by gemcitabine in advanced pancreatic adenocarcinoma: a case report. Last author DOI 10.1093/omcr/omad120↗
- Synchronous Primary Renal Cell Carcinoma and Pancreatic Ductal Adenocarcinoma: Case Report and Literature Review. Co-author DOI 10.1159/000484552↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Hassan Abdelilah Tafenzi · 1 shared paper, 2025
- Edwin Kelly Haag · 1 shared paper, 2023
- Mohamed Ichou · 1 shared paper, 2017
- Tarik Mahfoud · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.